Vaginal Douching
This process is often used to clean the vagina or address perceived odor or discharge.
However, the efficacy and safety of vaginal douching are controversial, with some research suggesting it may disrupt the natural vaginal microbiome and increase the risk of infections.
Most cited protocols related to «Vaginal Douching»
A complicating factor when studying intact females is accounting for variation in the ovarian cycle. Ideally, we would have used vaginal lavage before behavioral tests to identify females in diestrus, proestrus, or estrus before beginning social defeat or control training. However, lavage itself is stressful and has significant effects on behavior in female California mice ([30] (link); E. S. Davis personal communication). Because social defeat and control training was conducted across multiple days, each female was trained across multiple stages of the estrous cycle. Thus although variation in estrous cycle could influence the severity of each episode of defeat, multiple bouts of defeat ensured that this variation was not a confounding factor.
Most recents protocols related to «Vaginal Douching»
Following weaning, animals were housed in groups of 2–3 with same‐sex littermates, but were single housed starting ~2 weeks prior to behavioral testing per our previous studies.
Males and females were handled for 2 weeks prior to behavioral testing, and daily vaginal lavage was performed in the females to determine estrous cycle stage; males were handled similarly. Vaginal lavage was also performed after behavioral testing each day to assess the stage of the cycle during each behavioral test while avoiding additional handling stress.
The implantation of the BT applicator and needle was performed as described below: the applicator was selected before the surgery, according to the disease conditions of patients. The tumor location, size, shape, para-uterine invasion, and relationship with surrounding organs were verified from the MRI images before and after the EBRT, as well as gynecological examination. The bowel preparation was performed on the day before the operation, and vaginal irrigation was performed on the day of operation. Combined intravenous and inhalation anesthesia was administered to the patients, then the patients were disinfected routinely, and the Foley urethral catheter was placed, with the balloon at the site of the vesical neck. The color ultrasound-assisted implantation of the applicator and needle was performed. The applicators used included the Utrecht interstitial Fletcher CT/MRI applicator set, interstitial ring CT/MRI applicator set, vaginal CT/MRI multi-channel applicator set, and self-made 3D-printed applicator. In patients that the para-uterine invasion has reached the pelvic wall, trans-perineal manual implantation was performed in addition to the above-mentioned applicators to meet the demands of dose distribution, and the depth of the needle was guided under the assistance of ultrasound. After the completion of the implantation, the applicator and needles were fixed. For one BT fraction in one application and two BT fractions every other day in one application, the fixation method of the applicator and needles remained the same. First, the needles were fixed on the applicator using the guiding tube, which was assembled on the applicator. Next, the applicator was filled with gauze for internal fixation, and then it was externally fixed on the patient's body with a T-shaped fixing belt. And then the rectum was pushed by the rectal pressure plate. The MRI was performed after the patient has been awakened. The application of analgesic drugs was decided based on the level of pain in patients. The analgesic drugs included were as follows: patient-controlled intravenous analgesia (PCIA), subcutaneous injection of opiates, and/or anti-inflammatory analgesics. The analgesic drugs were used in the recovery and treatment periods according to the requirements.
T2W MRI of each BT fraction was used for the delineation of target volume and OARs, as referred to in the GEC-ESTRO recommendations [4 (link)]. The high-risk clinical target volume (HR-CTV) was applied for the range of tumors that showed by the MRI and physical examinations following the EBRT, as well as the overall uterine cervix examination. The intermediate-risk clinical target volume (IR-CTV) was applied for the range of cervical cancer before the EBRT and for the extension of HR-CTV. The OARs included the bladder, small intestine, sigmoid colon, and rectum.
All the patients received the HDR-IGABT treatment at the 28 Gy/4f. The MRI was performed on the day when the operation has been completed. The patients in Arm 1 have received one BT fraction, and then the applicator or needles have been removed, while the patients in Arm 2 have received the first BT fraction. CT has been performed 16–24 h later to verify the locations of the applicator and needles. The second BT fraction was performed after confirmation.
All the patients received routine medical nursing, and stretch socks were worn to prevent deep venous thrombosis (DVT). Continuous electrocardiogram (ECG), blood pressure, and blood oxygen saturation were monitored during the waiting period. Antiemetics and anxiolytics were provided based on patient assessment. For the patients who received BT fractions every other day in one application, the segmental pressing massager was used in the waiting period, and corresponding nursing practices were also adopted during the waiting period to maintain the patients in the supine position. In addition, one doctor and two nurses were assigned for nursing and closely monitoring the continuous BT patients.
HPV self-sampling, with respect to the clinician's sampling and analyzed by PCR-based assays, has a relative sensitivity and specificity of 95% and 92%, respectively, if we consider the most unfavourable scenarios, that is, a vaginal lavage to obtain the sample and the use of cell transport medium11 (link).
Approximately 40% of the women visiting the participating colposcopy clinic have HPV. This estimate was obtained from tests requested in that clinic.
Patients drop-out was estimated to be close to 0%, since all the health procedures of this research are performed on the same day, consecutively, and the main researcher is directly in charge of the pre-analytical phase.
Accuracy, or minimum value, of the difference to be detected is 0.1 and the chosen confidence level is 95%.
Criteria for inclusion and exclusion in the study.
Women between 35 and 65 years old |
Pregnancy and first six weeks of the puerperium |
Not having a cervix (prior hysterectomy or trachelectomy) |
Vaginal bleeding |
Use of medication, creams or vaginal douches in the last 48 h before sample collection |
Ignorance of the co-official languages of the Balearic Islands by the participant and, if applicable, by her companion |
Illiteracy in the strict or functional sense |
Inability to perform self-sampling |
Top products related to «Vaginal Douching»
More about "Vaginal Douching"
This process is often used to clean the vagina or address perceived odor or discharge.
The efficacy and safety of vaginal douching, however, are controversial, with some research suggesting it may disrupt the natural vaginal microbiome and increase the risk of infections.
Vaginal hygiene and health are important topics, and research has been conducted using various animal models, such as Sprague-Dawley rats, C57BL/6 mice, and Holtzman Sprague–Dawley rats.
Scientists have utilized techniques like Sabouraud dextrose agar plates and the Aurum Total RNA Fatty and Fibrous Tissue Kit to study the effects of vaginal douching and related interventions.
Some key subtopics in the field of vaginal douching include the potential benefits, such as addressing perceived odor or discharge, as well as the potential risks, including disruption of the vaginal microbiome and increased risk of infections.
Alternatives to douching, such as the use of probiotic supplements or B/B homodimerizer, have also been explored.
Researchers may use tools like PubCompare.ai to optimize their vaginal douching research, enabling them to easily locate and compare protocols from literature, pre-prints, and patents, ensuring reproducibility and accuracy.
This can enhance research efficiency and help find the best douching methods and products for vaginal health and hygiene needs.
Overall, the topic of vaginal douching is complex, with ongoing debates about its efficacy and safety.
Continued research, using both human and animal models, as well as the utilization of advanced tools and technologies, can provide valuable insights into this important aspect of women's health and hygiene.